Regulatory mechanisms and pathophysiological significance of IP3 receptors and ryanodine receptors in drug dependence

Journal of Pharmacological Sciences

Volumn 123, Issue 4, 2013, Pages 306-311

  Mizuno, Koji ^a   Kurokawa, Kazuhiro ^a   Ohkuma, Seitaro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

AP 1; Calcium channel; Drug dependence; Nuclear factor of activated T cells c4 (NFATc4); Type 1 inositol 1,4,5 trisphosphate receptors

Indexed keywords

ALCOHOL; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; METHAMPHETAMINE; NICOTINE; RYANODINE RECEPTOR; TRANSCRIPTION FACTOR NFAT;

CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; DRUG DEPENDENCE; DRUG MECHANISM; ENDOPLASMIC RETICULUM; NONHUMAN; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; REWARD; SIGNAL TRANSDUCTION; UPREGULATION;

CALCIUM; CALCIUM SIGNALING; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; NFATC TRANSCRIPTION FACTORS; PHOSPHORYLATION; RECEPTORS, DOPAMINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SUBSTANCE-RELATED DISORDERS; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 84892662357     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.13R07CP     Document Type: Review

References (45)

1. 3 and ryanodine receptors. Nature. 2012;483:108-112.
2. 2+ release channels. Physiol Rev. 2007;87:593-658.
3. 2+ channels (review). Mol Med Rep. 2010;3:199-204.
4. Wray S, Burdyga T. Sarcoplasmic reticulum function in smooth muscle. Physiol Rev. 2010;90:113-178.
5. Melamed E, Berman M, Lavy S. Letter: posterolateral myelopathy associated with thyrotoxicosis. N Engl J Med. 1975;293:778- 779.
6. Takei K, Shin RM, Inoue T, Kato K, Mikoshiba K. Regulation of nerve growth mediated by inositol 1,4,5-trisphosphate receptors in growth cones. Science. 1998;282:1705-1708.
7. Street VA, Bosma MM, Demas VP, Regan MR, Lin DD, Robinson LC, et al. The type 1 inositol 1,4,5-trisphosphate receptor gene is altered in the opisthotonos mouse. J Neurosci. 1997;17:635-645.
8. 3R3 protein knockdown. Neuropharmacology. 2008;55:1156-1164.
9. Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, Takano H, et al. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature. 1996;379:168-171.
10. Mattson MP, Chan SL. Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium. 2003;34:385-397.
11. Oulès B, Del Prete D, Greco B, Zhang X, Lauritzen I, Sevalle J, et al. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease. J Neurosci. 2012;32:11820-11834.
12. Chen X, Wu J, Lvovskaya S, Herndon E, Supnet C, Bezprozvanny I. Dantrolene is neuroprotective in Huntington's disease transgenic mouse model. Mol Neurodegener. 2011;6:81.
13. Shibasaki M, Kurokawa K, Ohkuma S. Upregulation of L-type Ca(v)1 channels in the development of psychological dependence. Synapse. 2010;64:440-444.
14. 2/δ-1 subunits of the voltage-gated calcium channels. Neuroscience. 2011;176:328-335.
15. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993;18:247-291.
16. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1:11-21.
17. 3 receptor subtypes. EMBO J. 1999;18:1303-1308.
18. 3 receptor isoforms. Biochem J. 2000;346 Pt 2:275-280.
19. Vermassen E, Parys JB, Mauger JP. Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell. 2004;96:3-17.
20. Faure AV, Grunwald D, Moutin MJ, Hilly M, Mauger JP, Marty I, et al. Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex. Eur J Neurosci. 2001;14:1613-1622.
21. Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci. 2005;8:1445-1449.
22. 3 receptor sensitization during in vivo amphetamine experience enhances NMDA receptor plasticity in dopamine neurons of the ventral tegmental area. J Neurosci. 2010;30:6689-6699.
23. Kurokawa K, Mizuno K, Ohkuma S. Possible involvement of type 1 inositol 1,4,5-trisphosphate receptors up-regulated by dopamine D1 and D2 receptors in mouse nucleus accumbens neurons in the development of methamphetamine-induced place preference. Neuroscience. 2012;227:22-29.
24. Kurokawa K, Mizuno K, Shibasaki M, Ohkuma S. Regulation of type 1 inositol 1,4,5-triphosphate receptor by dopamine receptors in cocaine-induced place conditioning. Synapse. 2012;66:180-186.
25. Genazzani AA, Carafoli E, Guerini D. Calcineurin controls inositol 1,4,5-trisphosphate type 1 receptor expression in neurons. Proc Natl Acad Sci U S A. 1999;96:5797-5801.
26. Graef IA, Mermelstein PG, Stankunas K, Neilson JR, Deisseroth K, Tsien RW, et al. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature. 1999;401:703-708.
27. Mizuno K, Kurokawa K, Ohkuma S. Dopamine D1 receptors regulate type 1 inositol 1,4,5-trisphosphate receptor expression via both AP-1- and NFATc4-mediated transcriptional processes. J Neurochem. 2012;122:702-713.
28. 3 receptor expression by dopamine D2-like receptors via AP-1 and NFATc4 activation. Neuropharmacology. 2013;71C:264-272.
29. Giannini G, Conti A, Mammarella S, Scrobogna M, Sorrentino V. The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J Cell Biol. 1995;28:893-904.
30. 2+ stores: ubiquitous partners of surface channels in neurons. News Physiol Sci. 2002;17:144-149.
31. Kurokawa K, Mizuno K, Kiyokage E, Shibasaki M, Toida K, Ohkuma S. Dopamine D1 receptor signaling system regulates ryanodine receptor expression after intermittent exposure to methamphetamine in primary cultures of midbrain and cerebral cortical neurons. J Neurochem. 2011;118:773-783.
32. Kurokawa K, Mizuno K, Shibasaki M, Ohkuma S. Dopamine D1 receptors participate in cocaine-induced place preference via regulation of ryanodine receptor expression. J Pharmacol Sci. 2011;117:87-97.
33. Kurokawa K, Shibasaki M, Kiyokage E, Mizuno K, Toida K, Ohkuma S. Involvement of NMDA receptors in ryanodine receptor expression in dopaminergic neurons in the ventral tegmental area of mice with intermittent methamphetamine treatment. Synapse. 2011;65:1156-1165.
34. Ziviani E, Lippi G, Bano D, Munarriz E, Guiducci S, Zoli M, et al. Ryanodine receptor-2 upregulation and nicotine-mediated plasticity. EMBO J. 2011;30:194-204.
35. Kurokawa K, Mizuno K, Shibasaki M, Ohkuma S. Regulation of ryanodine receptors by dopamine D1 receptors during methamphetamine-induced place conditioning. J Neurochem. 2010;115:1206-1214.
36. Kurokawa K, Mizuno K, Shibasaki M, Kiyokage E, Toida K, Ohkuma S. Cocaine increases ryanodine receptors via dopamine D1 receptors. Synapse. 2011;65:1106-1112.
37. 3 receptors. Synapse. 2013;67:51-55.
38. Tupala E, Tiihonen J. Dopamine and alcoholism: neurobiological basis of ethanol abuse. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:1221-1247.
39. Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, et al. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse. 2003;49:226-231.
40. B receptor modulation on dopamine D1 receptor and protein kinase A. Synapse. 2008;62:534-543.
41. A receptors. Mol Pharmacol. 2003;63:53-64.
42. A receptor plasticity after ethanol intoxication. J Neurosci. 2007;27: 12367-12377.
43. A receptors. Alcohol Clin Exp Res. 2009;33:289-299.
44. Kemppainen H, Raivio N, Kiianmaa K. Role for ventral pallidal GABAergic mechanisms in the regulation of ethanol self-administration. Psychopharmacology (Berl). 2012;223:211-221.
45. Samson HH, Chappell A. Muscimol injected into the medial prefrontal cortex of the rat alters ethanol self-administration. Physiol Behav. 2001;74:581-587.